Microsemi CRP Automated Hematology Analyzer Evaluated
By LabMedica International staff writers Posted on 05 Feb 2015 |
Complete blood counts (CBC) including white blood cell count (WBC) differentials and C-reactive protein (CRP) have been frequently utilized as the biomarkers for inflammatory diseases such as bacterial infection.
An automated hematology analyzer has been developed which can simultaneously measure CBC including three-part WBC differential (3-Diff) and CRP using ethylenediaminetetraacetic acid dipotassium salt dihydrate (EDTA-2K) anticoagulated whole blood without centrifugation for serum preparation.
Scientists at HORIBA Medical (Kyoto, Japan) used the company’s automated hematology analyzer, The Microsemi CRP, which is equipped with the electrical resistance method for CBC with 3-Diff of granulocytes (GRA) including neutrophils eosinophils and basophils, lymphocytes (LYM), and monocytes (MON). CRP is measured with the latex immune turbidimetry method following the prompt hemolyzation of EDTA-2K anticoagulated whole blood. The obtained value is then converted into plasma concentration according to hematocrit (HCT %) of respective sample to finally provide as ‘whole blood CRP.’
Correlation tests for the Microsemi CRP were compared with those of Micros CRP200, a preceding Horiba Medical model, and also those of the ADVIA 2120i (Siemens; Munich, Germany) routine hematology analyzer. The results of fresh whole blood and serum CRP obtained using Micros CRP200 were compared with those of serum CRP obtained using HITACHI 7600 routine analyzer (Tokyo, Japan).
The CBC data examined using Microsemi CRP showed excellent correlation with the previous model, Micros CRP200and also those obtained using the routine analyzer, ADVIA 2120i. In regards to the 3-Diff, both GRA (%) and LYM (%) showed the excellent correlation coefficient between Microsemi CRP and Micros CRP200 as well as ADVIA 2120i. (MON (%) showed good correlation between Microsemi CRP and Micros CRP200, but lower correlation between Microsemi CRP and ADVIA 2120. CRP data showed the good correlation with HITACHI 7600 and Micros CRP200.
The authors concluded that Microsemi CRP was a convenient laboratory analyzer which could provide the clinically reliable data about CBC including 3-Diff and CRP using only 18 μL whole blood within approximately four minutes. Therefore, Microsemi CRP seemed suitable in the setting of point of care testing (POCT) for the patients with inflammatory diseases such as bacterial infection, especially for pediatric ones in whom sufficient volume of samples necessary to simultaneous measurement of CBC including WBC Diff and CRP using the routine analyzers. The study was first published online on December 11, 2014, in the International Journal of Laboratory Hematology.
Related Links:
HORIBA Medical
Siemens
HITACHI
An automated hematology analyzer has been developed which can simultaneously measure CBC including three-part WBC differential (3-Diff) and CRP using ethylenediaminetetraacetic acid dipotassium salt dihydrate (EDTA-2K) anticoagulated whole blood without centrifugation for serum preparation.
Scientists at HORIBA Medical (Kyoto, Japan) used the company’s automated hematology analyzer, The Microsemi CRP, which is equipped with the electrical resistance method for CBC with 3-Diff of granulocytes (GRA) including neutrophils eosinophils and basophils, lymphocytes (LYM), and monocytes (MON). CRP is measured with the latex immune turbidimetry method following the prompt hemolyzation of EDTA-2K anticoagulated whole blood. The obtained value is then converted into plasma concentration according to hematocrit (HCT %) of respective sample to finally provide as ‘whole blood CRP.’
Correlation tests for the Microsemi CRP were compared with those of Micros CRP200, a preceding Horiba Medical model, and also those of the ADVIA 2120i (Siemens; Munich, Germany) routine hematology analyzer. The results of fresh whole blood and serum CRP obtained using Micros CRP200 were compared with those of serum CRP obtained using HITACHI 7600 routine analyzer (Tokyo, Japan).
The CBC data examined using Microsemi CRP showed excellent correlation with the previous model, Micros CRP200and also those obtained using the routine analyzer, ADVIA 2120i. In regards to the 3-Diff, both GRA (%) and LYM (%) showed the excellent correlation coefficient between Microsemi CRP and Micros CRP200 as well as ADVIA 2120i. (MON (%) showed good correlation between Microsemi CRP and Micros CRP200, but lower correlation between Microsemi CRP and ADVIA 2120. CRP data showed the good correlation with HITACHI 7600 and Micros CRP200.
The authors concluded that Microsemi CRP was a convenient laboratory analyzer which could provide the clinically reliable data about CBC including 3-Diff and CRP using only 18 μL whole blood within approximately four minutes. Therefore, Microsemi CRP seemed suitable in the setting of point of care testing (POCT) for the patients with inflammatory diseases such as bacterial infection, especially for pediatric ones in whom sufficient volume of samples necessary to simultaneous measurement of CBC including WBC Diff and CRP using the routine analyzers. The study was first published online on December 11, 2014, in the International Journal of Laboratory Hematology.
Related Links:
HORIBA Medical
Siemens
HITACHI
Read the full article by registering today, it's FREE!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
- Free digital version edition of LabMedica International sent by email on regular basis
- Free print version of LabMedica International magazine (available only outside USA and Canada).
- Free and unlimited access to back issues of LabMedica International in digital format
- Free LabMedica International Newsletter sent every week containing the latest news
- Free breaking news sent via email
- Free access to Events Calendar
- Free access to LinkXpress new product services
- REGISTRATION IS FREE AND EASY!
Sign in: Registered website members
Sign in: Registered magazine subscribers
Latest Hematology News
- Next Generation Instrument Screens for Hemoglobin Disorders in Newborns
- First 4-in-1 Nucleic Acid Test for Arbovirus Screening to Reduce Risk of Transfusion-Transmitted Infections
- POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy
- First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy
- Handheld White Blood Cell Tracker to Enable Rapid Testing For Infections
- Smart Palm-size Optofluidic Hematology Analyzer Enables POCT of Patients’ Blood Cells
- Automated Hematology Platform Offers High Throughput Analytical Performance
- New Tool Analyzes Blood Platelets Faster, Easily and Accurately
- First Rapid-Result Hematology Analyzer Reports Measures of Infection and Severity at POC
- Bleeding Risk Diagnostic Test to Reduce Preventable Complications in Hospitals
- True POC Hematology Analyzer with Direct Capillary Sampling Enhances Ease-of-Use and Testing Throughput
- Point of Care CBC Analyzer with Direct Capillary Sampling Enhances Ease-of-Use and Testing Throughput
- Blood Test Could Predict Outcomes in Emergency Department and Hospital Admissions
- Novel Technology Diagnoses Immunothrombosis Using Breath Gas Analysis
- Advanced Hematology System Allows Labs to Process Up To 119 Complete Blood Count Results per Hour
- Unique AI-Based Approach Automates Clinical Analysis of Blood Data